
0:00
10:09
Pyridostigmine enhances neuromuscular transmission and is commonly used to treat myasthenia gravis. The effect of pyridostigmine in slowing ALS progression is uncertain. Here we discuss the potential mechanisms, cases, clinical trial data, and potential risks.
Altri episodi di "CReATe Podcast"



Non perdere nemmeno un episodio di “CReATe Podcast”. Iscriviti all'app gratuita GetPodcast.








